Angiotensin Converting Enzyme (ACE) Inhibitors Market - Global Outlook and Forecast 2022-2028
An angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure.
This report contains market size and forecasts of Angiotensin Converting Enzyme (ACE) Inhibitors in global, including the following market information:
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Angiotensin Converting Enzyme (ACE) Inhibitors companies in 2021 (%)
The global Angiotensin Converting Enzyme (ACE) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sulfhydryl-containing Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors include Abbott Laboratories, Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiotensin Converting Enzyme (ACE) Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment Percentages, by Type, 2021 (%)
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment Percentages, by Application, 2021 (%)
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Angiotensin Converting Enzyme (ACE) Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Angiotensin Converting Enzyme (ACE) Inhibitors revenues share in global market, 2021 (%)
Key companies Angiotensin Converting Enzyme (ACE) Inhibitors sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Angiotensin Converting Enzyme (ACE) Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Angiotensin Converting Enzyme (ACE) Inhibitors in global, including the following market information:
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Angiotensin Converting Enzyme (ACE) Inhibitors companies in 2021 (%)
The global Angiotensin Converting Enzyme (ACE) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sulfhydryl-containing Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors include Abbott Laboratories, Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiotensin Converting Enzyme (ACE) Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment Percentages, by Type, 2021 (%)
- Sulfhydryl-containing Agents
- Dicarboxylate-containing Agents
- Phosphonate-containing Agents
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment Percentages, by Application, 2021 (%)
- Hypertension
- Cardiovascular Diseases
- Kidney Diseases
- Other
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Angiotensin Converting Enzyme (ACE) Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Angiotensin Converting Enzyme (ACE) Inhibitors revenues share in global market, 2021 (%)
Key companies Angiotensin Converting Enzyme (ACE) Inhibitors sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Angiotensin Converting Enzyme (ACE) Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Pfizer
- Novartis
- Merck
- Astra Zeneca
- Jhonson and Johnson
- Eli Lilly
- Sanofi
- Bristol-Myers Squibb
- Bayer
- GSK
- Teva Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS OVERALL MARKET SIZE
2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size: 2021 VS 2028
2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Angiotensin Converting Enzyme (ACE) Inhibitors Players in Global Market
3.2 Top Global Angiotensin Converting Enzyme (ACE) Inhibitors Companies Ranked by Revenue
3.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Companies
3.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Companies
3.5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Angiotensin Converting Enzyme (ACE) Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Angiotensin Converting Enzyme (ACE) Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Angiotensin Converting Enzyme (ACE) Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Angiotensin Converting Enzyme (ACE) Inhibitors Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Markets, 2021 & 2028
4.1.2 Sulfhydryl-containing Agents
4.1.3 Dicarboxylate-containing Agents
4.1.4 Phosphonate-containing Agents
4.2 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue & Forecasts
4.2.1 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2022
4.2.2 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2023-2028
4.2.3 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales & Forecasts
4.3.1 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2022
4.3.2 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2023-2028
4.3.3 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2021 & 2028
5.1.2 Hypertension
5.1.3 Cardiovascular Diseases
5.1.4 Kidney Diseases
5.1.5 Other
5.2 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue & Forecasts
5.2.1 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2022
5.2.2 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2023-2028
5.2.3 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales & Forecasts
5.3.1 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2022
5.3.2 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2023-2028
5.3.3 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue & Forecasts
6.2.1 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2022
6.2.2 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2023-2028
6.2.3 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales & Forecasts
6.3.1 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2022
6.3.2 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2023-2028
6.3.3 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.4.2 By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.4.3 US Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.4.4 Canada Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.4.5 Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.5.2 By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.5.3 Germany Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.4 France Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.5 U.K. Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.6 Italy Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.7 Russia Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.8 Nordic Countries Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.9 Benelux Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.6.2 By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.6.3 China Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6.4 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6.5 South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6.6 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6.7 India Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.7.2 By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.7.3 Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.7.4 Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.8.3 Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.8.4 Israel Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.8.5 Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.8.6 UAE Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.1.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.2.4 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.3.4 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.4.4 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.4.5 Merck Key News
7.5 Astra Zeneca
7.5.1 Astra Zeneca Corporate Summary
7.5.2 Astra Zeneca Business Overview
7.5.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.5.4 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.5.5 Astra Zeneca Key News
7.6 Jhonson and Johnson
7.6.1 Jhonson and Johnson Corporate Summary
7.6.2 Jhonson and Johnson Business Overview
7.6.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.6.4 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.6.5 Jhonson and Johnson Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.7.4 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.7.5 Eli Lilly Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.8.4 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.8.5 Sanofi Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.9.4 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.9.5 Bristol-Myers Squibb Key News
7.10 Bayer
7.10.1 Bayer Corporate Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.10.4 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.10.5 Bayer Key News
7.11 GSK
7.11.1 GSK Corporate Summary
7.11.2 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Business Overview
7.11.3 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.11.4 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.11.5 GSK Key News
7.12 Teva Pharmaceutical
7.12.1 Teva Pharmaceutical Corporate Summary
7.12.2 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Business Overview
7.12.3 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.12.4 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.12.5 Teva Pharmaceutical Key News
8 GLOBAL ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity, 2017-2028
8.2 Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS SUPPLY CHAIN ANALYSIS
10.1 Angiotensin Converting Enzyme (ACE) Inhibitors Industry Value Chain
10.2 Angiotensin Converting Enzyme (ACE) Inhibitors Upstream Market
10.3 Angiotensin Converting Enzyme (ACE) Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Angiotensin Converting Enzyme (ACE) Inhibitors Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS OVERALL MARKET SIZE
2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size: 2021 VS 2028
2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Angiotensin Converting Enzyme (ACE) Inhibitors Players in Global Market
3.2 Top Global Angiotensin Converting Enzyme (ACE) Inhibitors Companies Ranked by Revenue
3.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Companies
3.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Companies
3.5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Angiotensin Converting Enzyme (ACE) Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Angiotensin Converting Enzyme (ACE) Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Angiotensin Converting Enzyme (ACE) Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Angiotensin Converting Enzyme (ACE) Inhibitors Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Markets, 2021 & 2028
4.1.2 Sulfhydryl-containing Agents
4.1.3 Dicarboxylate-containing Agents
4.1.4 Phosphonate-containing Agents
4.2 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue & Forecasts
4.2.1 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2022
4.2.2 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2023-2028
4.2.3 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales & Forecasts
4.3.1 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2022
4.3.2 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2023-2028
4.3.3 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2021 & 2028
5.1.2 Hypertension
5.1.3 Cardiovascular Diseases
5.1.4 Kidney Diseases
5.1.5 Other
5.2 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue & Forecasts
5.2.1 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2022
5.2.2 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2023-2028
5.2.3 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales & Forecasts
5.3.1 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2022
5.3.2 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2023-2028
5.3.3 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue & Forecasts
6.2.1 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2022
6.2.2 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2023-2028
6.2.3 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales & Forecasts
6.3.1 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2022
6.3.2 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2023-2028
6.3.3 By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.4.2 By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.4.3 US Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.4.4 Canada Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.4.5 Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.5.2 By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.5.3 Germany Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.4 France Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.5 U.K. Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.6 Italy Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.7 Russia Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.8 Nordic Countries Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.5.9 Benelux Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.6.2 By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.6.3 China Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6.4 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6.5 South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6.6 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.6.7 India Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.7.2 By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.7.3 Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.7.4 Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales, 2017-2028
6.8.3 Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.8.4 Israel Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.8.5 Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
6.8.6 UAE Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.1.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.2.4 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.3.4 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.4.4 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.4.5 Merck Key News
7.5 Astra Zeneca
7.5.1 Astra Zeneca Corporate Summary
7.5.2 Astra Zeneca Business Overview
7.5.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.5.4 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.5.5 Astra Zeneca Key News
7.6 Jhonson and Johnson
7.6.1 Jhonson and Johnson Corporate Summary
7.6.2 Jhonson and Johnson Business Overview
7.6.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.6.4 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.6.5 Jhonson and Johnson Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.7.4 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.7.5 Eli Lilly Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.8.4 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.8.5 Sanofi Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.9.4 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.9.5 Bristol-Myers Squibb Key News
7.10 Bayer
7.10.1 Bayer Corporate Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.10.4 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.10.5 Bayer Key News
7.11 GSK
7.11.1 GSK Corporate Summary
7.11.2 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Business Overview
7.11.3 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.11.4 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.11.5 GSK Key News
7.12 Teva Pharmaceutical
7.12.1 Teva Pharmaceutical Corporate Summary
7.12.2 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Business Overview
7.12.3 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Major Product Offerings
7.12.4 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Revenue in Global (2017-2022)
7.12.5 Teva Pharmaceutical Key News
8 GLOBAL ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity, 2017-2028
8.2 Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS SUPPLY CHAIN ANALYSIS
10.1 Angiotensin Converting Enzyme (ACE) Inhibitors Industry Value Chain
10.2 Angiotensin Converting Enzyme (ACE) Inhibitors Upstream Market
10.3 Angiotensin Converting Enzyme (ACE) Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Angiotensin Converting Enzyme (ACE) Inhibitors Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors in Global Market
Table 2. Top Angiotensin Converting Enzyme (ACE) Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Companies, (K MT), 2017-2022
Table 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
Table 9. List of Global Tier 1 Angiotensin Converting Enzyme (ACE) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angiotensin Converting Enzyme (ACE) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2017-2022
Table 15. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2023-2028
Table 16. By Application – Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2017-2022
Table 20. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2023-2028
Table 21. By Region – Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2017-2022
Table 25. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2023-2028
Table 26. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 29. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 30. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 33. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 34. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 37. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 38. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 41. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 46. Abbott Laboratories Corporate Summary
Table 47. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 48. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 51. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Novartis Corporate Summary
Table 53. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 54. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Merck Corporate Summary
Table 56. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 57. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Astra Zeneca Corporate Summary
Table 59. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 60. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Jhonson and Johnson Corporate Summary
Table 62. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 63. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Eli Lilly Corporate Summary
Table 65. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 66. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 69. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Bristol-Myers Squibb Corporate Summary
Table 71. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 72. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Bayer Corporate Summary
Table 74. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 75. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. GSK Corporate Summary
Table 77. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 78. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Teva Pharmaceutical Corporate Summary
Table 80. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 81. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 83. Global Angiotensin Converting Enzyme (ACE) Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production by Region, 2017-2022 (K MT)
Table 85. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production by Region, 2023-2028 (K MT)
Table 86. Angiotensin Converting Enzyme (ACE) Inhibitors Market Opportunities & Trends in Global Market
Table 87. Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers in Global Market
Table 88. Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints in Global Market
Table 89. Angiotensin Converting Enzyme (ACE) Inhibitors Raw Materials
Table 90. Angiotensin Converting Enzyme (ACE) Inhibitors Raw Materials Suppliers in Global Market
Table 91. Typical Angiotensin Converting Enzyme (ACE) Inhibitors Downstream
Table 92. Angiotensin Converting Enzyme (ACE) Inhibitors Downstream Clients in Global Market
Table 93. Angiotensin Converting Enzyme (ACE) Inhibitors Distributors and Sales Agents in Global Market
Table 1. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors in Global Market
Table 2. Top Angiotensin Converting Enzyme (ACE) Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Companies, (K MT), 2017-2022
Table 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
Table 9. List of Global Tier 1 Angiotensin Converting Enzyme (ACE) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angiotensin Converting Enzyme (ACE) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2017-2022
Table 15. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2023-2028
Table 16. By Application – Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2017-2022
Table 20. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2023-2028
Table 21. By Region – Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2017-2022
Table 25. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), 2023-2028
Table 26. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 29. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 30. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 33. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 34. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 37. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 38. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 41. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales, (K MT), 2023-2028
Table 46. Abbott Laboratories Corporate Summary
Table 47. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 48. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 51. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Novartis Corporate Summary
Table 53. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 54. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Merck Corporate Summary
Table 56. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 57. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Astra Zeneca Corporate Summary
Table 59. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 60. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Jhonson and Johnson Corporate Summary
Table 62. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 63. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Eli Lilly Corporate Summary
Table 65. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 66. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 69. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Bristol-Myers Squibb Corporate Summary
Table 71. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 72. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Bayer Corporate Summary
Table 74. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 75. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. GSK Corporate Summary
Table 77. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 78. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Teva Pharmaceutical Corporate Summary
Table 80. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product Offerings
Table 81. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 83. Global Angiotensin Converting Enzyme (ACE) Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production by Region, 2017-2022 (K MT)
Table 85. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production by Region, 2023-2028 (K MT)
Table 86. Angiotensin Converting Enzyme (ACE) Inhibitors Market Opportunities & Trends in Global Market
Table 87. Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers in Global Market
Table 88. Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints in Global Market
Table 89. Angiotensin Converting Enzyme (ACE) Inhibitors Raw Materials
Table 90. Angiotensin Converting Enzyme (ACE) Inhibitors Raw Materials Suppliers in Global Market
Table 91. Typical Angiotensin Converting Enzyme (ACE) Inhibitors Downstream
Table 92. Angiotensin Converting Enzyme (ACE) Inhibitors Downstream Clients in Global Market
Table 93. Angiotensin Converting Enzyme (ACE) Inhibitors Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Type
Figure 2. Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Application
Figure 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Angiotensin Converting Enzyme (ACE) Inhibitors Revenue in 2021
Figure 9. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 19. US Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 33. China Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Angiotensin Converting Enzyme (ACE) Inhibitors by Region, 2020 VS 2027
Figure 50. Angiotensin Converting Enzyme (ACE) Inhibitors Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Type
Figure 2. Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Application
Figure 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Angiotensin Converting Enzyme (ACE) Inhibitors Revenue in 2021
Figure 9. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 19. US Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 33. China Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Angiotensin Converting Enzyme (ACE) Inhibitors by Region, 2020 VS 2027
Figure 50. Angiotensin Converting Enzyme (ACE) Inhibitors Industry Value Chain
Figure 51. Marketing Channels
